Healthcare -
Biotechnology - NASDAQ - US
$ 15.04
-3.16 %
$ 1.19 B
Market Cap
-3.48
P/E
VRDN - GROSS PROFIT
Gross Profit VRDN - Viridian Therapeutics, Inc.
-1.01 M
LAST VALUE
-19.59%
2 YEAR CAGR
46.04%
5 YEAR CAGR
-4.51%
10 YEAR CAGR